FAM20C and Insulin resistance: Overall, our data not only validate Fam20c as a key mediator of insulin resistance in adipocytes but also suggest that inhibition of Fam20c may serve as a promising therapeutic approach to alleviate obesity-induced metabolic dysfunction.